Sign In
Buy RVMD
$155.99
+4.68 (+3.09%)
At Close: Jun 03, 2026
SG Americas Securities LLC Has $500,000 Holdings in Revolution Medicines, Inc. $RVMD
04:56am, Sunday, 25'th Jan 2026
SG Americas Securities LLC increased its position in shares of Revolution Medicines, Inc. (NASDAQ: RVMD) by 150.4% in the third quarter, according to its most recent disclosure with the Securities and
First Look: Fed Probe, Bank Cap Shock, Gold Soars, Deals
07:38am, Tuesday, 13'th Jan 2026
Stock News DOJ subpoenas Fed chair spark backlash: Federal prosecutors served grand jury subpoenas to Jerome Powell over testimony on Fed HQ renovations, prompt
Revolution Medicines, Inc. (RVMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
05:26pm, Monday, 12'th Jan 2026
Revolution Medicines, Inc. (RVMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of “Buy” by Analysts
01:10am, Monday, 12'th Jan 2026
Shares of Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) have been given an average rating of "Buy" by the eighteen research firms that are currently covering the company, Marketbeat.com
Defense, AI power demand and deal-driven catalysts powered last week's top large-cap winners, led by sharp surges in RGC, RVMD and a cluster of defense and data-center energy plays.
Jack Anders Sells 10,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock
05:12am, Sunday, 11'th Jan 2026
Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) CFO Jack Anders sold 10,000 shares of Revolution Medicines stock in a transaction dated Wednesday, January 7th. The stock was sold at an ave
Why Revolution Medicines Stock Surged by 11% Today
07:56pm, Friday, 09'th Jan 2026
It's apparently in talks to be sold to a pharmaceutical industry titan. The price being discussed reaches into the tens of billions of dollars.
Deal Dispatch: Saks Faces A Luxury Liquidity Crisis, Soho House Gets Quiet
04:46pm, Friday, 09'th Jan 2026
Dealmaking persists as creditors, buyers, and investors wrestle with debt, delays, and mega-merger ambitions.
Merck is in talks to acquire Revolution Medicines in a deal that could value the cancer-drug biotech at around $30 billion
02:58pm, Friday, 09'th Jan 2026
Revolution is developing drugs that target a molecular driver of cancers.
Revolution Medicines: "Strong Buy" As Acquisition Prospects Continue To Circle
02:33pm, Friday, 09'th Jan 2026
Revolution Medicines (RVMD) remains a "Strong Buy", driven by advanced RAS [ON] inhibitor programs and robust clinical progress, notably with Daraxonrasib. Company's phase 3 RASolute-302 trial in meta
Merck in Talks to Buy Revolution Medicines Per Financial Times Report
01:06pm, Friday, 09'th Jan 2026
Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.
Merck Eyes Revolution Medicines in a Potential $32 Billion Deal
11:14am, Friday, 09'th Jan 2026
Merck (MRK) is reportedly in talks to acquire Revolution Medicines (RVMD) for $28-$32 billion or more. This acquisition aims to strengthen MRK's oncology pipeli
First Look: GM's $7.1B EV Charge, Paramount's $30 WBD Bid
07:38am, Friday, 09'th Jan 2026
Stock News xAI under fire over Grok image edits: Elon Musk's xAI (private) restricted Grok's image generation/editing on X to paying users after the tool was us
Breakfast News: TSM Defies Bubble Fears
07:30am, Friday, 09'th Jan 2026
TSM enjoys revenue surge, Nvidia adds CMO for brand recognition, jobs report due, and more
Revolution Medicines Stock Soars. Takeover Buzz Grows, Another Suitor Emerges.
05:54am, Friday, 09'th Jan 2026
Revolution Medicines stock was soaring again early Friday after a report that Merck is in talks to buy the cancer-drug biotech for up to $32 billion.
